Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.120ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.120NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AM.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
AM.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AA.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.1.249ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.249ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.249ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.249NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AA.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.505ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.505ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.505ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.505NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.74ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.74NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-54.8415US
B.1.406ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.406ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.406NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.115ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.115ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.115ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.115NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AA.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.1.133ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.133ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.133ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.133NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used